Expert Insights on GCT Cold Chain Logistics
-
Establishing A Critical Supply Chain For Autologous Cell And Gene Therapies
11/15/2018
With the recent breakthroughs in cell and gene therapy, there is increased emphasis on the design and implementation of different supply chain models to support the movement of materials and drug product across the chain of care. Unlike more traditional supply chains, many of these therapies have unpredictable sources and manufacturing and infusion locations. The most extreme example is loosely referred to as the “vein-to-vein” supply chain — particularly for autologous therapies.
-
Environmental Risks & The Life Science Supply Chain: Lessons Learned From Hurricane Maria
1/15/2018
Looking back at the hurricane season from the perspective of supply chain risk — and specifically risks that have impacted the life sciences supply chain — there are many lessons to be learned.
-
5 Proven Steps To Successfully Select & Onboard Outsourced Logistics Partners
1/23/2017
In preceding articles in this series, we reviewed some of the challenges and remediation approaches for the storage and distribution of life science products, highlighting some of the specific risks related to storage, transportation, and material control across an extended chain of custody. This brings us to the final article, in which we will discuss best practices for selecting the partners that will be an extension of your staff for monitoring and control across an ever-changing global landscape.